semaglutide mash therapy enters a more competitive era Semaglutide approved for MASH treatment:

By Nancy Lapid June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis suggests

Many people report getting GLP-1s through online telemedicine companies, where a doctor is required to evaluate and prescribe the drug, but barriers to entry can be too low

Disposal of used vials and syringes follows standard sharps safety protocols

GLP-1 prescriptions grew from ~9M in Q4 2022 (source) to ~24M by Q4 2024 (source)

Using real world electronic medical record (EMR) data, we find that women experience more than double the rates of persistent nausea and vomiting when prescribed GLP1R agonists

Choosing between Zepbound and semaglutide GLP-1 is a decision that should be made with your healthcare provider